-
EP2585038
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2585038
| EP2585038 - PHARMACEUTICAL COMPOSITION COMPRISING MIDAZOLAM [Right-click to bookmark this link] | Status | The application has been refused Status updated on 09.02.2018 Database last updated on 16.11.2024 | Most recent event Tooltip | 09.02.2018 | Refusal of application | published on 14.03.2018 [2018/11] | Applicant(s) | For all designated states Special Products Limited Unit 16 Trade City Avro Way Weybridge, Surrey KT13 0YF / GB | [2013/18] | Inventor(s) | 01 /
MARCH, Graham, Alan Unit 16 Avro Way Brooklands Business Park Weybridge Surrey KT13 0YF / GB | [2013/18] | Representative(s) | Hutter, Anton Venner Shipley LLP The Surrey Technology Centre The Surrey Research Park 40 Occam Road Guildford, Surrey GU2 7YG / GB | [2014/41] |
| Former [2013/25] | Smaggasgale, Gillian Helen WP Thompson 55 Drury Lane London WC2B 5SQ / GB | ||
| Former [2013/18] | Murray, Adrian D'Coligny WP Thompson 55 Drury Lane London WC2B 5SQ / GB | Application number, filing date | 11728923.1 | 20.06.2011 | WO2011GB51146 | Priority number, date | GB20100010453 | 22.06.2010 Original published format: GB 201010453 | [2013/18] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2011161439 | Date: | 29.12.2011 | Language: | EN | [2011/52] | Type: | A1 Application with search report | No.: | EP2585038 | Date: | 01.05.2013 | Language: | EN | The application published by WIPO in one of the EPO official languages on 29.12.2011 takes the place of the publication of the European patent application. | [2013/18] | Search report(s) | International search report - published on: | EP | 29.12.2011 | Classification | IPC: | A61K9/00, A61K9/08, A61K31/5517, A61P25/08, A61P25/20, A61P23/00, A61K47/10, A61K47/48 | [2013/18] | CPC: |
A61K31/5517 (EP,GB,US);
A61K9/0031 (EP,GB,US);
A61K45/06 (EP,US);
A61K47/10 (EP,US);
A61K9/0043 (EP,GB,US);
A61K9/006 (EP,GB,US);
A61K9/08 (EP,GB,US);
A61P23/00 (EP);
A61P25/08 (EP);
A61P25/20 (EP)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2013/18] | Title | German: | PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT MIDAZOLAM | [2013/18] | English: | PHARMACEUTICAL COMPOSITION COMPRISING MIDAZOLAM | [2013/18] | French: | COMPOSITION PHARMACEUTIQUE COMPRENANT DU MIDAZOLAM | [2013/18] | Entry into regional phase | 10.12.2012 | National basic fee paid | 10.12.2012 | Designation fee(s) paid | 10.12.2012 | Examination fee paid | Examination procedure | 10.12.2012 | Examination requested [2013/18] | 09.09.2013 | Amendment by applicant (claims and/or description) | 27.01.2015 | Despatch of a communication from the examining division (Time limit: M04) | 15.05.2015 | Reply to a communication from the examining division | 05.10.2017 | Cancellation of oral proceeding that was planned for 16.11.2017 | 27.10.2017 | Despatch of communication that the application is refused, reason: substantive examination [2018/11] | 06.11.2017 | Application refused, date of legal effect [2018/11] | 16.11.2017 | Date of oral proceedings (cancelled) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 27.01.2015 | Fees paid | Renewal fee | 10.04.2013 | Renewal fee patent year 03 | 20.06.2014 | Renewal fee patent year 04 | 17.06.2015 | Renewal fee patent year 05 | 29.06.2016 | Renewal fee patent year 06 | 21.06.2017 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XDI]WO0130391 (FARMARC NEDERLAND BV [NL], et al); | [X]WO03004015 (WEST PHARM SERV DRUG RES LTD [GB], et al); | [X]WO2005067893 (MERKUS FRANCISCUS WILHELMUS HE [BE]); | by applicant | WO0130391 | EP1323422 | GB20090022357 |